Induction of dopamine biosynthesis by l-DOPA in PC12 cells: Implications of l-DOPA influx and cyclic AMP

European Journal of Pharmacology

Volumn 591, Issue 1-3, 2008, Pages 88-95

  Jin, Chun Mei ^a   Yang, Yoo Jung ^a   Huang, Hai Shan ^a   Lim, Sung Cil ^a   Kai, Masaaki ^b   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cyclic AMP; Dopamine biosynthesis; Dopamine D1 receptor; l DOPA; l DOPA influx; PC12 cell; Tyrosine hydroxylase

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; DOPAMINE 1 RECEPTOR; LEVODOPA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DECARBOXYLATION; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DECARBOXYLATION; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LEVODOPA; PC12 CELLS; RATS; RECEPTORS, DOPAMINE D1; SIGNAL TRANSDUCTION; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 48749095667     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.052     Document Type: Article

References (43)

1. Boyce S., Rupniak N.M., Steventon M.J., and Iversen S.D. Nigrostriatal damage is required for induction of dyskinesias by l-DOPA in squirrel monkeys. Clin. Neuropharmacol. 13 (1990) 448-458
2. Campbell D.G., Hardie D.G., and Vulliet P.R. Identification of four phosphorylation sites in the N-terminal region of tyrosine hydroxylase. J. Biol. Chem. 261 (1986) 10489-10492
3. Charon I., Zuin-Kornmann G., Bataille S., and Schordert M. Protective effect of neurotrophic factors, neuropoietic cytokines and dibutyryl cyclic AMP on hydrogen peroxide-induced cytotoxicity on PC12 cells: a possible link with the state of differentiation. Neurochem. Int. 33 (1999) 503-511
4. Cheng N.N., Maeda T., Kume T., Kaneko S., Kochiyama H., Akaike A., Goshima Y., and Misu Y. Differential neurotoxicity induced by l-DOPA and dopamine in cultured striatal neurons. Brain Res. 743 (1996) 278-283
5. Cho S., Neff N.H., and Hadjiconstantinou M. Regulation of tyrosine hydroxylase and aromatic l-amino acid decarboxylase by dopaminergic drugs. Eur. J. Pharmacol. 323 (1997) 149-157
6. Dairman W., and Udenfriend S. Decrease in adrenal tyrosine hydroxylase and increase in norepinephrine synthesis in rats given l-DOPA. Science 171 (1971) 1022-1024
7. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann. Rev. Neurosci. 15 (1992) 285-320
8. Gjedde A., Léger G.C., Cummings P., Yasuhara Y., Evans A.C., Guttman M., and Kuwabara H. Striatal l-DOPA decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis. J. Neurochem. 61 (1993) 1538-1541
9. Gonzalez G.A., and Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59 (1989) 675-680
10. Haycock J.W. Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31 and 40. J. Biol. Chem. 265 (1990) 11682-11691
11. Joh T.H., Park D.H., and Reis D.J. Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: mechanism of enzyme activation. Proc. Natl. Acad. Sci. USA 75 (1978) 4744-4748
12. Juorio A.V., and Boulton A.A. The effect of some precursor amino acids and enzyme inhibitors on the mouse striatal concentration of tyramines and homovanillic acid. J. Neurochem. 39 (1982) 859-863
13. Kim K.S., Lee M.K., Carroll J., and Joh T.H. Basal and inducible transcription of the tyrosine hydroxylase gene are dependent upon a cyclic AMP response element. J. Biol. Chem. 268 (1993) 15689-15695
14. Kim K.S., Park D.H., and Joh T.H. Parallel up-regulation of catecholamine biosynthesis enzymes by dexamethasone in PC12 cells. J. Nurochem. 60 (1993) 946-951
15. Kim K.S., Tinti C., Song B., Cubells J.F., and Joh T.H. Cyclic AMP-dependent protein kinase regulated basal and cyclic AMP-stimulated but not phorbol ester-stimulated transcription of the tyrosine hydroxylase gene. J. Neurochem. 63 (1994) 834-842
16. Koshimura K., Tanaka J., Murakami Y., and Kato Y. Effects of dopamine and l-DOPA on survival of PC12 cells. J. Neurosci. Res. 62 (2000) 112-119
17. Lambeng N., Michel P.P., Agid Y., and Ruberg M. The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor. Neurosci. Lett. 297 (2001) 133-136
18. Lee J.J., Kim Y.M., Yin S.Y., Park H.D., Kang M.H., Hong J.T., and Lee M.K. Aggravation of l-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66 (2003) 1787-1795
19. Li R., Peng N., Li X.P., and Le W.D. (-)-Epigallocatechin gallate regulates dopamine transporter internalization via protein kinase C-dependent pathway. Brain Res. 1097 (2006) 85-89
20. Lowry O.H., Rosenbrough N.L., Farr A.L., and Randall R.L. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. Marsden C.D. Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 57 (1994) 672-681
22. Migheli R., Godani C., Sciola L., Delogu M.R., Serra P.A., Zangani D., De Natale G., Miele E., and Desole M.S. Enhancing effect of manganese on l-DOPA-induced apoptosis in PC12 cells: Role of oxidative stress. J. Neurochem. 73 (1999) 1155-1163
23. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78 (1998) 189-225
24. Montminy M. Transcriptional regulation by cyclic AMP. Ann. Rev. Biochem. 66 (1997) 807-822
25. Morelli M., Cozzolino A., Pinna A., Fenu S., Carta A., and Di Chiara G. l-DOPA stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors. Brain Res. 623 (1993) 334-336
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Method 65 (1983) 55-63
27. Nagatsu T., Oka K., and Kato K. Highly sensitive assay for tyrosine hydroxylase activity by high performance liquid chromatography. J. Chromatogr. 63 (1979) 247-252
28. Nanmoku T., Takekoshi K., Fukuda T., Isobe K., Shibuya S., and Kawakami Y. Urocortin stimulates tyrosine hydroxylase activity via the cyclic AMP /protein kinase a pathway in rat Pheochromocytoma PC12 cells. Neurosci. Lett. 382 (2005) 124-127
29. Neve K.A., Seamans J.K., and Trantham-Davidson H. Dopamine receptor signaling. J. Recept Signal Transduct. Res. 24 (2004) 165-205
30. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., and Riccardi C. A rapid simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Method 139 (1991) 271-279
31. Piiper A., Dikic I., Lutz M.P., Lesser J., Kronenberger B., Elez R., Cramer H., Muller-Esterl W., and Zeuzem S. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. J. Biol. Chem. 277 (2002) 43623-43630
32. Robertson H.A. Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends Neurosci. 15 (1992) 201-206
33. Sanchez S., Jimenez C., Carrera A.C., Diaz-Nido J., Avila J., and Wandosell F. A cyclic AMP -activated pathway, including PKA and PI3K, regulated neuronal differentiation. Neurochem. Int. 44 (2004) 231-242
34. Segal R.A., and Greenburg M.E. Intracellular signaling pathways activated by neurotrophic factors. Ann. Rev. Neurosci. 19 (1996) 463-489
35. Spector S., Mata R.O., Sjoerdsma A., and Udenfriend S. Biochemical and pharmacological effects of iodo-tyrosines; relation to tyrosine hydroxylase inhibition in vivo. Life Sci. 4 (1965) 1307-1311
36. Sutherland C., Alterio J., Campbell D.G., Le Bourdelles B., Mallet J., Haavik J., and Cohen P. Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur. J. Biochem. 217 (1993) 715-722
37. Tarver J., Berkowitz B., and Spector S. Alterations in tyrosine hydroxylase and monoamine oxidase activity in blood vessels. Natl. New Biol. 231 (1971) 252-253
38. Tischler A.S., Perlman R.L., Morse G.M., and Sheard B.E. Glucocorticoids increase catecholamine synthesis and storage in PC12 cells pheochromocytoma cell culture. J. Neurochem. 40 (1983) 364-370
39. Wakinshaw G., and Waters C.M. Induction of apoptosis in catecholaminergic PC12 cells by l-DOPA. Implications for the treatment of Parkinson's disease. J. Clin. Invest. 95 (1995) 2458-2468
40. Yin S.Y., Kim Y.M., Lee J.J., Jin C.M., Yang Y.J., Ma J.J., Kang M.H., Kai M., and Lee M.K. Enantio-selective inhibition of (1R,9S)- and (1S,9R)-b-hydrastines on dopamine biosynthesis in PC12 cells. Neuropharmacol. 47 (2004) 1045-1052
41. Young E.A., Duchemin A.-M., Neff N.H., and Hadjiconstantinou M. Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathways. Eur. J. Pharmacol. 357 (1998) 15-23
42. Zachor D.A., Moore J.F., Brezausek C., Therbert A., and Percy A.K. Cocaine inhibits NGF-induced PC12 cells differentiation through D1-type dopamine receptors. Brain Res. 869 (2000) 85-97
43. Zhou B., Li F., Chen H., and Song J. The modulation of apoptosis by cyclic AMP involves Akt and epidermal growth factor receptor. Int. J. Biochem. Cell Biol. 37 (2005) 1483-1495